// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Sub-Haploinsufficiency of BMPR2 Causes a Shift in the Endothelial Proliferative and Metabolic Response to BMP9

A. L. Theilmann - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Tet2 Deletion In Hematopoietic Cells Contributes To Pulmonary Arterial Hypertension Development.

F. Potus - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Interleukin

Lymphangioleiomyomatosis-Derived Smooth Muscle Cells (LAM-SMCs) Destabilize Endothelial Cell (EC) Networks While ECs Promote Growth of LAM-SMCs

M. Ho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Fibrotic Extracellular Matrix Induces Exosomal Pro-Fibrotic miRNA Production of Fibrocytes

S. Sato - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

DE-074

Real-Time Imaging of Mechanical Stress-Induced ATP Release in Rat Lungs: from In Vitro to Ex Vivo

J. Tan - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association Between Obstructive Sleep Apnea and Motor Symptoms in Parkinson’s Disease Patients

L. Meng - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Levodopa

Persistence of Sleep-Disordered Breathing from Pregnancy to the Postpartum Period

A. M. Al-Dobyany - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Protein Kinase C, L-Type Voltage-Gated Calcium Channels and Non-Muscle Myosin II Are Involved in ‘Force Adaptation’

M. Gazzola - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

SK1211

Right Ventricular Dysfunction in Pulmonary Hypertension Due to Chronic Lung Disease: Male Gender Is Associated with RV-PA Uncoupling

L. Rose - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Improvements in Functional Image Impedance Modelling of Asthmatic Lungs Using K-Means Clustering

C. Church - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Carbocysteine

Effects of Inhaled Corticosteroids on Distal Airway Inflammation in COPD Patients: The DISARM Study

Y. Cho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

fluticasone / salmeterol powder

Effectiveness and Safety of Direct Switch to Indacaterol/Glycopyrronium from Previous Treatments in Patients with Moderate-to-Severe COPD: The POWER Study

A. McIvor - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Seebri Breezhaler

Investigating Airway Reflexes by Assessing Capsaicin Evoked Cough Responses in an Allergen Challenge Model of Asthma

I. Satia - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

SK1211

Incident Diuretic Drug Use and Adverse Respiratory Events Among Older Adults with COPD

N. Vozoris - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Fluids in Septic Shock (FISSH): A Pilot Randomized Controlled Trial

B. Rochwerg - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Lung Ultrasound and Microbubbles Enhance Aminoglycoside Efficacy in the Lung in E.Coli-Induced Pneumonia and ARDS

W. L. Lee - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Gentamicin

Heart Rate Variability: Can It Be Used as a Vital Sign in Critically Ill Monitored Patients?

G. L. Jones - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Angiography in Out of Hospital Cardiac Arrest Without ST-Elevation; Selection Bias Accounts for the Relationship to Survival: A Single Center Retrospective Cohort Analysis

J. Shaw - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Individualized Prediction of Lung Function Decline in the General Adult Population

W. Chen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Engaging Stakeholders to Improve Care: Barriers and Facilitators in Primary Care Delivery for Sleep Disordered Breathing

S. R. Pendharkar - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved